Chan et al (2012) reported significantly decreased STAT1 in human neoplastic tissue of ER+ breast tumors and showed that knocking out STAT1 in a mouse model correlated with the development of ER+PR+ luminal A adenocarcinoma [77]. This evidence concerns the gene STAT1 and breast neoplasm.